Biosimilars: To Infinity and Beyond - On Demand

Recorded On: 11/14/2023

What is the future of biosimilars in the home and alternate site? There are numerous options now available and even now interchangeable options. We will take a look at various concepts related to biosimilars including transition from the parent product to a biosimilar, determining what is interchangeable, and more. 

Learning Objectives:

  1. Review the legislative impact for pharmacies as it relates to interchangeability of approved molecules in clinical practice. 
  2. Review current requirements for FDA approval of biosimilars and interchangeability requirements for biosimilars.
  3. Describe potential processes to overcome barriers to biosimilar adoption (prescribing, financial, operational).

Jonathan Ogurchak, PharmD, CSP

Co-Founder & CEO


Jonathan Ogurchak is the Founder & CEO of STACK, a compliance management software designed to simplify the “outside of the dispense” complexities associated with running successful pharmacy organizations. He is also Managing Partner of Rhythm Group, consulting and technology solutions organization, and is a Certified Consultant with Accreditation Commission for Health Care (ACHC). Jonathan has designed programs and services for both Accredo and PANTHERx Specialty Pharmacy focusing on implementing innovative uses for technology, including high-touch pharmacist-driven programs focused on dosing efficiency, clinical monitoring of patient outcomes, and integrated patient engagement. Jonathan is on faculty for the Master of Pharmacy Business Administration (MPBA) program through the University of Pittsburgh, leading the Specialty Pharmacy Management curriculum. He currently serves on the editorial board for Specialty Pharmacy Times, holds CSP Certification through the Specialty Pharmacy Certification Board, and serves as an Educational Consultant for the National Association of Specialty Pharmacy (NASP). 

No Disclosures to Report


Biosimilars: To Infinity and Beyond
Recorded 11/14/2023  |  30 minutes
Recorded 11/14/2023  |  30 minutes
Post Webinar Quiz
5 Questions  |  2 attempts  |  80/100 points to pass
5 Questions  |  2 attempts  |  80/100 points to pass
Post Education Survey
5 Questions
5 Questions Clinical Connect: Biosimilars: To Infinity and Beyond - 0.5 CE Credit 0761-9999-23-557-L01-P&T & 05-115-23-395 RN/RD
Required to Claim CE
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** _______________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.